Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai announced results from the Phase 3 LEAP-015 trial evaluating KEYTR...
Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Applicati...
Following the adoption of a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
Extended Collaboration with Sartorius Powers New Biomanufacturing Lab at McMaster University, Canada State-of-the-art bioprocessing au...
ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing ther...
President Donald J. Trump has signed an executive order initiating the withdrawal of the United States from the World Health Organization (WHO). Th...
3-year grant received from the Bill & Melinda Gates Foundation to enhance RNA production technologies Grant enables global implementation of the ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced additional positive Phase 3 results in adolescents for it...
Tanvex BioPharma, Inc. (“Tanvex”), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars product...
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, announced its innovative drug development strategy in the rigorous and cutti...
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced its latest business achievements a...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, wil...
© 2025 Biopharma Boardroom. All Rights Reserved.
